Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer
| Autor: | Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, Shahan ul Quraish, Munazzah Naz, Mohammad Abdul Razzaq |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Cancer Informatics, Vol 21 (2022) |
| Druh dokumentu: | article |
| ISSN: | 1176-9351 11769351 |
| DOI: | 10.1177/11769351221076062 |
| Popis: | Cancer is a leading cause of morbidity and mortality worldwide. Over the past decades, the concept of precision cancer medicine has emerged as a novel approach in the field of oncology that aims to tailor the most effective treatment options to each individual cancer patient based on the genetic profile of the tumor of each individual patient. Recently, tissue biopsy has become an essential part of cancer care and is widely used to characterize the tumor. However, tissue biopsy techniques face different challenges due to their invasiveness, cost, time, and adversity in potential sampling due to tissue heterogeneity. To overcome these issues, a non-invasive approach has developed, which is known as liquid biopsy. It is a simple, fast, and worthwhile technique based on the analysis of circulating tumor DNA (which is a fraction of cfDNA), circulating tumor cells (CTCs), and other tumor-derived material in blood plasma. This review provides an overview of the concept of liquid biopsy and briefly discusses the role of ctDNA and CTC analysis as tools for early diagnosis and prognosis of cancer. In this review, we also speculate on the advantages of liquid biopsy as opposed to tissue biopsy and postulate that liquid biopsy may be a comprehensive approach to overcome the current limitations associated with costly, invasive, and time-consuming tissue biopsy. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|